Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells.
Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells.
复制标题
DOI:
10.1016/j.immuni.2012.05.025
复制
发表时间:
2012-08
期刊:
影响因子:
32.4
通讯作者:
Nir Yogev;Friederike Frommer;D. Lukas;Kordula Kautz-Neu;K. Karram;D. Ielo;E. von Stebut;H. Probst-H.-Probs
中科院分区:
文献类型:
--
作者:
Nir Yogev;Friederike Frommer;D. Lukas;Kordula Kautz-Neu;K. Karram;D. Ielo;E. von Stebut;H. Probst-H.-Probs
Mature dendritic cells (DCs) are established as unrivaled antigen-presenting cells (APCs) in the initiation of immune responses, whereas steady-state DCs induce peripheral T cell tolerance. Using various genetic approaches, we depleted CD11c+DCs in mice and induced autoimmune CNS inflammation. Unexpectedly, mice lacking DCs developed aggravated disease compared to control mice. Furthermore, when we engineered DCs to present a CNS-associated autoantigen in an induced manner, we found robust tolerance that prevented disease, which coincided with an upregulation of the PD-1 receptor on antigen-specific T cells. Additionally, we showed that PD-1 was necessary for DC-mediated induction of regulatory T cells. Our results show that a reduction of DCs interferes with tolerance, resulting in a stronger inflammatory response, and that other APC populations could compensate for the loss of immunogenic APC function in DC-depleted mice.